Complex I and Parkinson's disease

292Citations
Citations of this article
153Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Complex I of the mammalian electron transfer chain is composed of at least 43 protein subunits, of which 7 are encoded by mtDNA. It catalyzes the transfer of electrons from NADH to ubiquinone and translocates protons from the mitochondrial matrix to the intermembrane space. It may also play direct roles in the mitochondrial permeability transition and in cell death pathways. Despite the limitations of current complex I assays, biochemical studies have suggested the presence of a mild, systemic defect of complex I in Parkinson's disease (PD). Recent experimental work has modeled this abnormality using rotenone to systemically inhibit complex I. Chronic rotenone exposure accurately recapitulated the pathological, biochemical, and behavioral features of PD. Thus, relatively subtle complex I abnormalities-either genetic or acquired-may be central to the pathogenesis of PD.

Cite

CITATION STYLE

APA

Greenamyre, J. T., Sherer, T. B., Betarbet, R., & Panov, A. V. (2001, September 1). Complex I and Parkinson’s disease. IUBMB Life. Taylor and Francis Inc. https://doi.org/10.1080/15216540152845939

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free